Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Vials of Johnson & Johnson's coronavirus vaccine in Oakland, California, on March 26. Photo: Gabrielle Lurie/The San Francisco Chronicle via Getty Images

A Baltimore plant run by Emergent BioSolutions that produces coronavirus vaccines ruined a batch of Johnson & Johnson’s vaccine, according to a statement released by Johnson & Johnson Wednesday.

Why it matters: The plant, which was projected to produce and ship tens of millions of Johnson & Johnson doses next month, must now cease producing the one-dose vaccine while the Food and Drug Administration investigates the error, the New York Times first reported. Axios confirmed the report is accurate.

Context: Workers at the plant, which had been producing Johnson & Johnson and AstraZeneca vaccines, conflated the ingredients between the two different types of vaccines, destroying 15 million doses of Johnson & Johnson vaccine, according to the Times.

  • The error should not affect Johnson & Johnson doses currently being delivered and administered nationwide, as they were produced in the Netherlands.
  • The Emergent BioSolutions plant had not yet been authorized by the FDA to manufacture drug substance for Johnson & Johnson's vaccine, but an authorization application had been pending, according to Politico.

What they're saying: Johnson & Johnson said Wednesday that its "quality control process identified one batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet authorized to manufacture drug substance for our COVID-19 vaccine."

  • "This batch was never advanced to the filling and finishing stages of our manufacturing process," the company added.
  • Johnson & Johnson said it is sending manufacturing and quality control experts to the plant to oversee future production.

Thought bubble, via Axios' Caitlin Owens: The Times says the accident won't stop the U.S. from reaching President Biden's goal of having enough vaccine by the end of May for every adult, but in the global race against the virus, every dose counts.

Go deeper

Caitlin Owens, author of Vitals
Mar 31, 2021 - Health

Demand for vaccines is already waning in some parts of the country

Expand chart
Reproduced from U.S. Census Bureau; Chart: Axios Visuals

Some states are expanding vaccine eligibility partially because of a troubling reason: Not enough people want to get vaccinated.

What we're watching: Vaccine supplies are still limited, but they're already outpacing demand in some parts of the country, especially rural areas. And that could be a bad sign for the future.

Mar 31, 2021 - Health

Advocates warn: The clock is ticking on new variants

Illustration: Aïda Amer/Axios

Some experts say the world may only have a year or less to stave off a new round of COVID-19 variants that could evade the existing vaccines, according to survey conducted by advocates trying to speed up vaccinations in developing nations.

Why it matters: Variants emerge when viruses spread widely, so quickly vaccinating the entire world is the best way to curb new variants. But some experts are afraid we won't get there fast enough.

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Brendan Lynch/Axios

  1. Health: Emergency room visits of all kinds dropped amid the pandemic — NY smart-thermometer network could predict next COVID wave.
  2. Vaccines: FDA clears 10 million J&J vaccine doses from contaminated Baltimore plant — Moderna asks FDA to expand COVID-19 vaccine authorization to adolescents.
  3. Cities: Seattle becomes first major city to get 70% fully vaccinated — Schools nationwide prepare for packed kindergartens this fall.
  4. Work: Goldman Sachs requires U.S. employees to report vaccination status.
  5. Politics: U.S. to buy 500 million Pfizer doses to share with the world — State Department eases travel advisories for dozens of countries.
  6. World: Moscow orders new restrictions amid surge in COVID-19 cases — 12 Venezuela players, staff contract COVID-19 before Copa America opener — 2021 already has a higher global coronavirus death toll than 2020.
  7. 🎧 Podcast: Back to normal without herd immunity.
  8. Variant tracker: Where different strains are spreading.